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Background
The antipsychotic drug risperidone has become increas-
ingly popular as a treatment for children with various
behavioral disorders, including autism. However, little is
known about the long-term effects of early-life risperidone
treatment on the brain and behavior. The frontal cortex is
one of the primary targets of risperidone action in the
brain, so the purpose of this study was to determine if
early-life risperidone treatment altered neurotrophin
expression in the prefrontal cortex during adulthood.
Materials and methods
Twenty-four rats (13 females, 11 males) received daily
injections from postnatal days 14-42. Rats were divided
into two treatment groups (1.0 and 3.0 mg/kg risperidone)
and a vehicle control. Brain tissue was collected on post-
natal day 62. Prefrontal cortical tissue from the left hemi-
sphere was examined for neurotrophin expression through
the use of a rat neurotrophin RT-PCR array kit (SABios-
ciences, Inc.). Sections of prefrontal cortex were also used
for immunohistochemistry.
Results
PCR results indicated an up-regulation of mRNA for the
cytokine, Leukemia Inhibitory Factor (LIF), in the low
and high dose treatment groups. Immunohistochemistry
is being conducted to assess possible differences in LIF
protein levels in the prefrontal cortex of the different
treatment groups.
Conclusion
This study indicates that early-life risperidone treatment
has the potential to alter the expression of proteins
involved in cell growth and differentiation with brain
regions critical for cognitive control. The behavioral
consequences of these cellular changes are an area that
further research should address.
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